Damage-sensing mechanisms in human cells after ionizing radiation

Stem Cells

Volumn 15, Issue SUPPL. 2, 1997, Pages 27-42

  Boothman, David A ^a   Burrows, Heather L ^a   Yang, Chin Rang ^a   Davis, Thomas W ^a   Wuerzberger, Shelly M ^a   Planchon, Sarah M ^a   Odegaard, Eric ^a   Lewis, Janet E ^a   Pink, John ^a   Meyers, Mark ^a   Wilson Van Patten, Carmell ^a   Sharda, Navneet ^a   Kinsella, Timothy J ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Immediate early genes; Poly(ADP ribose) polymerase; Retinoblastoma control proteins; SpI; Topoisomerase I

Indexed keywords

DNA TOPOISOMERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL REGENERATION; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IONIZING RADIATION; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0030659417     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150707     Document Type: Conference Paper

References (127)

1. Teoule R. Radiation-induced DNA damage and its repair. Int J Radial Biol Relat Stud Phys Chem Med 1987;51:573-589.
2. Hagen U. Current aspects on the radiation induced base damage in DNA. Radiat Environ Biophys 1986;25:261-271.
3. Collins A. Cellular responses to ionizing radiation: effects of interrupting DNA repair with chemical agents. Int J Radiat Biol Relat Stud Phys Chem Med 1987;51:971-983.
4. Ward JF. Ionizing radiation induced DNA damage: identities and DNA repair. Basic Life Sci 1986;38;135-138.
5. Ward JF. The complexity of DNA damage: relevance to biological consequences. Int J Radiat Biol 1994;66:427-432.
6. Hall EJ, Astor M, Bedford J et al. Basic radiobiology. Am J Clin Oncol 1988;11:220-252.
7. Mitchel RE, Morrison DP. An oxygen effect for gamma-radiation induction of radiation resistance in yeast. Radiat Res 1984;100:205-210.
8. Bankson DD, Kestin M, Rifai N. Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993;13:463-480.
9. Emerit J, Klein JM, Coutellier A et al. Free radicals and lipid peroxidation in cell biology: physiopathologic prospects. Pathol Biol (Paris) 1991;39:316-327.
10. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995;18:1033-1077.
11. Gantchev TG. Thymidine free radicals generated during metallo-phthalocyanine photosensitization: a comparison with gamma-radiation. Int J Radiat Biol 1995;68:29-36.
12. Peak JG, Ito T, Robb FT et al. DNA damage produced by exposure of supercoiled plasmid DNA to high- and low-LET ionizing radiation: effects of hydroxyl radical quenchers. Int J Radiat Biol 1995;67:1-6.
13. Pribush A, Agam G, Yermiahu T et al. Radiation damage to the erythrocyte membrane: the effects of medium and cell concentrations. Free Radic Res 1994;21;135-146.
14. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994;65:27-33.
15. Tyshkin SM, Taranenko VM, Rudniev MI et al. Activation of free-radical processes as a factor of ionizing radiation-induced changes in contractile activity of a vascular wall. Fiziol Zh 1993;39:23-29.
16. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 1992;275:331-342.
17. Billen D. Free radical scavenging and the expression of potentially lethal damage in X-irradiated repair-deficient Escherichia coli. Radiat Res 1987;111:354-360.
18. Koi M, Umar A, Chauhan DP et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation (published erratum appears in Cancer Res 1995;55:201). Cancer Res 1994;54:4308-4312.
19. Hawn MT, Umar A, Carethers JM et al. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res 1995;55:3721-3725.
20. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038.
21. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-261.
22. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-5063.
23. Reid TM, Fry M, Loeb LA. Endogenous mutations and cancer. Princess Takamatsu Symp 1991;22:221-229.
24. Boothman DA, Bouvard I, Hughes EN. Identification and characterization of x-ray-induced proteins in human cells. Cancer Res 1989;49:2871-2878.
25. Boothman DA, Trask DK, Pardee AB. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Res 1989;49:605-612.
26. Mezzina M, Nocentini S, Sarasin A. DNA ligase activity in carcinogen-treated human fibroblasts. Biochimie 1982;64:743-748.
27. Chang C, Biedermann KA, Mezzina M et al. Characterization of the DNA double strand break repair defect in seid mice. Cancer Res 1993;53:1244-1248.
28. Datta R, Hass R, Gunji H et al. Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ 1992;3:637-644.
29. Reed SI, Bailly E, Dulic V et al. G1 control in mammalian cells. J Cell Sci 1994;18:69-73 (suppl).
30. Di Leonardo A, Linke SP, Clarkin K et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cipl in normal human fibroblasts. Genes Dev 1994;8:2540-2551.
31. Franklin CC, Unlap T, Adler V et al. Multiple signal transduction pathways mediate c-Jun protein phosphorylation. Cell Growth Differ 1993;4:377-385.
32. Coffer PJ, Burgering BM, Peppelenbosch MP et al. UV activation of receptor tyrosine kinase activity. Oncogene 1995;11:561-569.
33. Kim CY, Giaccia AJ, Strulovici B et al. Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation. Br J Cancer 1992;66:844-849.
34. 2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 1994;54:12-15.
35. Engel K, Ahlers A, Brach MA et al. MAPKAP kinase 2 is activated by heat shock and TNF-alpha: in vivo phosphorylation of small heat shock protein results from stimulation of the MAP kinase cascade. J Cell Biochem 1995;57:321-330.
36. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992;356:356-358.
37. Prigent C, Lasko DD, Kodama K et al. Activation of mammalian DNA ligase I through phosphorylation of casein kinase II. EMBO J 1992;11:2925-2933.
38. Shah G, Ghosh R, Amstad PA et al. Mechanism of induction of c-fos by ultraviolet B (290-320 nm) in mouse JB6 epidermal cells. Cancer Res 1993;53:38-45.
39. Sahijdak WM, Yang CR, Zuckerman JS et al. Alterations in transcription factor binding in radioresistant human melanoma cells after ionizing radiation. Radiat Res 1994;138:S47-S51.
40. Boothman DA, Fukunaga N, Wang M. Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res 1994;54:4618-4626.
41. Amstad PA, Knipitza G, Cerutti PA. Mechanism of c-fos induction by active oxygen. Cancer Res 1992;52:3952-3960.
42. Belka C, Wiegmann K, Adam D et al. Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J 1995;14:1156-1165.
43. Brach MA, Gruss HJ, Kaisho T et al. Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem 1991;268:8466-8472.
44. Gruss HJ, Brach MA, Hermann F. Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor. Blood 1992;80:2563-2570.
45. Sherman ML, Datta R, Hallahan DE et al. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci USA 1990;87:5663-5666.
46. Xanthoudakis S, Miao G, Wang F et al. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992;11:3323-3335.
47. Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 1992;11:653-665.
48. Xanthoudakis S, Miao GG, Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci USA 1994;91:23-27.
49. Yao KS, Xanthoudakis S, Curran T et al. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994;14:5997-6003.
50. Boothman DA, Wang M, Lee SW. Induction of tissue-type plasminogen activator by ionizing radiation in human malignant melanoma cells. Cancer Res 1991;51:5587-5595.
51. Boothman DA, Greer S, Pardee AB. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione), a novel DNA repair inhibitor. Cancer Res 1987;47:5361-5366.
52. Hughes EN, Boothman DA. Effect of caffeine on the expression of a major x-ray induced protein in human tumor cells. Radiat Res 1991;125:313-317.
53. Russell WC, Newman C, Williamson DH. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature 1975;253:461-462.
54. Maniatis T, Frisch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Press, 1982.
55. Hollander MC, Fornace A.J., Jr. Estimation of relative mRNA content by filter hybridization to a polythymidylate probe. Biotechniques 1990;9:174-179.
56. Fukunaga N, Burrows HL, Meyers M et al. Enhanced induction of tissue-type plasminogen activator in normal human cells compared to cancer-prone cells following ionizing radiation. Int J Radiat Oncol Biol Phys 1992;24:949-957.
57. Boothman DA, Meyers M, Fukunaga N et al. Isolation of x-ray-inducible transcripts from radioresistant human melanoma cells. Proc Natl Acad Sei USA 1993;90:7200-7204.
58. Trask DK, Muller MT. Biochemical characterization of topoisomerase I purified from avian erythrocytes. Nucleic Acids Res 1983;11:2779-2800.
59. Trask DK, DiDonato JA, Muller MT. Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II. EMBO J 1984;3:671-676.
60. Boothman DA, Lee IW, Sahijdak WM. Isolation of an x-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of x-ray-responsive elements for gene therapy. Radiat Res 1994;138:S68-S71.
61. Boothman DA, Davis TW, Sahijdak WM. Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int J Radiat Oncol Biol Phys 1994;30:391-398.
62. Meyers M, Shea R, Seabury H et al. Role of x-ray-induced genes and proteins in adaptive survival responses. In: Sugahara T, Sagan L, Aoyama, T, eds. Low Dose Irradiation and Biological Defense Mechanisms. Amsterdam, The Netherlands: Elsevier Science Publishers, 1992:263-266.
63. Boothman DA, Hughes EN, Pardee AB. The role of x-ray-induced DNA repair processes in mutagenesis and carcinogenesis. Prog Clin Biol Res 1990;340E:319-327.
64. Woloschak GE, Chang-Liu CM, Jones PS et al. Modulation of gene expression in Syrian hamster embryo cells following ionizing radiation. Cancer Res 1990;50:339-344.
65. Woloschak GE, Felcher P Chang-Liu CM. Expression of cytoskeletal and matrix genes following exposure to ionizing radiation: dose-rate effects and protein synthesis requirements. Cancer Lett 1995;92:135-141.
66. Singh SP, Lavin MF. DNA-binding protein activated by gamma radiation in human cells. Mol Cell Biol 1990;10:5279-5285.
67. Datta R, Rubin E, Sukhatme V et al. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 1992;89:10149-10153.
68. Weichselbaum RR, Hallahan DE, Sukhatme VP et al. Gene therapy targeted by ionizing radiation. Int J Radiat Oncol Biol Phys 1992;24:565-567.
69. Weichselbaum RR, Hallahan DE, Beckett MA et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994;54:4266-4269.
70. Graeber TG, Peterson JF, Tsai M et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994;14:6264-6277.
71. Rosselli F, Ridet A, Soussi T et al. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995;10:9-17.
72. Girinsky T, Koumenis C, Graeber TG et al. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 1995;55:3726-3731.
73. Udvadia AJ, Templeton DJ, Horowitz JM. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA 1995;92:3953-3957.
74. Hagen G, Muller S, Beato M et al. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 1994;13:3843-3851.
75. Prasad AV, Mohan N, Chandrasekar B et al. Induction of transcription of immediate early genes by low-dose ionizing radiation. Radiat Res 1995;143:263-272.
76. Kim SJ, Onwuta US, Lee YI et al. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 1992;12:2455-2463.
77. Udvadia AJ, Rogers KT, Horowitz JM. A common set of nuclear factors bind to promoter elements regulated by the retinoblastoma protein. Cell Growth Differ 1992;3:597-608.
78. Udvadia AJ, Rogers KT, Higgins PD et al. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci USA 1993;90:3265-3269.
79. Chen LI, Nishinaka T, Kwan K et al. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol Cell Biol 1994;14:4380-4389.
80. Jensen DE, Rich CB, Terpstra AJ et al. Transcriptional regulation of the elastin gene by insulin-like growth factor-I involves disruption of Sp1 binding. Evidence for the role of Rb in mediating Sp1 binding in aortic smooth muscle cells. J Biol Chem 1995;270:6555-6563.
81. Shaw P, Bovey R, Tardy S et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;89:4495-4499.
82. Lowe SW, Ruley HE, Jacks T et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
83. Fiscella M, Ullrich SJ, Zambrano N et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 1993;8:1519-1528.
84. Ullrich SJ, Sakaguchi K, Lees-Miller SP et al. Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci USA 1993;90:5954-5958.
85. Jackson SP, MacDonald JJ, Lees-Miller S et al. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 1990;63:155-165.
86. Boothman DA, Majmudar G, Johnson T. Immediate x-ray-inducible responses from mammalian cells. Radiat Res 1994;138:S44-S46.
87. Woloschak GE, Felcher P, Changliu CM. Combined effects of ionizing radiation and cycloheximide on gene expression. Mol Carcinog 1995;13:44-49.
88. Boothman DA, Pardee AB. Inhibition of radiation-induced neoplastic transformation by beta-lapachone. Proc Natl Acad Sci USA 1989;86:4963-4967.
89. Boothman DA, Wang M, Schea RA et al. Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int J Radiat Oncol Biol Phys 1992;24:939-948.
90. Mattern MR, Hofmann GA, McCabe FL et al. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Res 1991;51:5813-5816.
91. Kim JH, Kim SH, Kolozsvary A et al. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. Int J Radiat Oncol Biol Phys 1992;22:515-518.
92. Fleischmann G, Pflugfelder G, Steiner EK et al. Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. Proc Natl Acad Sci USA 1984;81:6958-6962.
93. Trask DK, Muller MT. Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. Proc Natl Acad Sci USA 1988;85:1417-1421.
94. Hsiang YH, Wu HY Liu LF. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 1988;48:3230-3235.
95. Crumplin GC. The involvement of DNA topoisomerases in DNA repair and mutagenesis. Carcinogenesis 1981;2:157-160.
96. Bendixen C, Thomsen B, Alsner J et al. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry 1990;29:5613-5619.
97. Kaufmann WK, Boyer JC, Estabrooks LL et al. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes. Mol Cell Biol 1991;11:3711-3718.
98. Zhang H, Wang JC, Liu LF. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci USA 1988;85:1060-1064.
99. Crespi MD, Mladovan AG, Baldi A. Increment of DNA topoisomerases in chemically and virally transformed cells. Exp Cell Res 1988;175:206-215.
100. Husain I, Mohler JL, Seigler HF et al. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 1994;54:539-546.
101. Boothman DA. Enhanced malignant transformation is accompanied by increased survival recovery after ionizing radiation in Chinese hamster embryo fibroblasts. Radiat Res 1994;138:S121-S125.
102. Lamond JP, Kinsella TJ, Wang M et al. Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitors. Int J Radiat Oncol Biol Phys 1996;36:369-376.
103. Lamond JP, Kinsella TJ, Wang M et al. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation. Int J Radiat Oncol Biol Phys 1996;36:361-368.
104. Shall S. ADP-ribosylation, DNA repair, cell differentiation and cancer. Princess Takamatsu Symp 1983;13:3-25.
105. Durkacz BW, Omiji O, Gray DA et al. (ADP-ribose) participates in DNA excision repair. Nature 1980;283:593-596.
106. Nduka N, Skidmore CJ, Shall S. The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase. Eur J Biochem 1980;105:525-530.
107. Durban E, Mills JS, Roll D et al. Phosphorylation of purified Novikoff hepatoma topoisomerase I. Biochem Biophys Res Commun 1983;111:897-905.
108. Mattern MR, Mong SM, Bartus HF et al. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res 1987;47:1793-1798.
109. Sebolt-Leopold JS, Scavone SV. Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor. Int J Radiat Oncol Biol Phys 1992;22:619-621.
110. Lindahl T. DNA glycosylases, endonucleases for apurinic/apyrimidinic sites, and base excision-repair. Prog Nucleic Acid Res Mol Biol 1979;22:135-192.
111. Bryant PE. Immediate and repair induced DNA double strand breaks in mammalian cells. In: Simic MG, Grossman L, Upton AC, eds. Mechanisms of DNA Damage and Repair. New York: Plenum Publishing Company, 1986:171-180.
112. Ahnstrom G, Bryant PE. DNA double-strand breaks generated by the repair of x-ray damage in Chinese hamster cells. Int J of Cancer 1982;41:671-676.
113. Bryant PE, Waring R, Ahnstrom G. DNA repair kinetics after low doses of x-rays: a comparison of results obtained by the unwinding and nucleoid sedimentation methods. Mutat Res 1984;131:19-26.
114. Tan KB, Mattern MR, Eng WK et al. Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. J Natl Cancer Inst 1985;81:1732-1735.
115. Been MD, Champoux JJ. Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing. J Mol Biol 1984;180:515-531.
116. Been MD, Champoux JJ. Breakage of single-stranded DNA by rat liver nicking-closing enzyme with the formation of a DNA-enzyme complex. Nucleic Acids Res 1980;8:6129-6142.
117. Been MD, Champoux JJ. DNA breakage and closure by rat liver type 1 topoisomerase: separation of the half-reactions by using a single-stranded DNA substrate. Proc Natl Acad Sci USA 1981;78:2883-2887.
118. Dean FB, Cozzarelli NR. Mechanism of strand passage by Escherichia coli topoisomerase I. The role of the required nick in catenation and knotting of duplex DNA. J Biol Chem 1985;260:4984-4994.
119. McCoubrey Jr. WK, Champoux JJ. The role of single-strand breaks in the catenation reaction catalyzed by the rat type I topoisomerase. J Biol Chem 1986;261:5130-5137.
120. Prell B, Vosberg HP. Analysis of covalent complexes formed between calf thymus DNA topoisomerase and single-stranded DNA. Eur J Biochem 1980;108:389-398.
121. Hsiang YH, Hertzberg R, Hecht S et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985;260:14873-14878.
122. Li CJ, Averboukh L, Pardee AB. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem 1993;268:22463-22468.
123. Yeh YC, Liu HF, Ellis CA et al. Mammalian topoisomerase I has base mismatch nicking activity. J Biol Chem 1994;269:15498-15504.
124. Kaufmann SH, Desnoyers S, Ottaviano Y et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993;53:3976-3985.
125. Casciola-Rosen LA, Miller DK, Anhalt GJ et al. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Biol Chem 1995;269:30757-30760.
126. Beidler DR, Tewari M, Friesen PD et al. The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem 1995;270:16526-16528.
127. Clem RJ, Hardwick JM, Miller LK. Anti-apoptotic genes of baculoviruses. Cell Death Differ 1996;3:9-16.